WallStreetZenWallStreetZen

NASDAQ: BTCY
Biotricity Inc Earnings & Revenue

BTCY past revenue growth

How has BTCY's revenue growth performed historically?
Company
28.55%
Industry
10.68%
Market
15.28%
BTCY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BTCY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BTCY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BTCY earnings and revenue history

Current Revenue
$11.6M
Current Earnings
-$15.4M
Current Profit Margin
-132.3%

BTCY Return on Equity

Insufficient data to display

Be the first to know when BTCY announces earnings.

BTCY Return on Assets

Current Company
-246.5%
Current Industry
5.3%
BTCY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BTCY Return on Capital Employed

Current Company
80.27%
Current Industry
8.3%
BTCY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BTCY vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BTCY$11.63M-$9.92M-$15.39M+121.10%N/A
NXL$158.86k-$4.90M-$4.94M-39.39%N/A
BMRA$5.41M-$5.94M-$6.35M+0.91%N/A
NURO$5.27M-$7.91M-$7.98M-18.06%N/A
INBS$3.21M-$8.76M-$10.03M+184.43%N/A

BTCY earnings dates

Next earnings date
Jun 28, 2024

Biotricity Earnings & Revenue FAQ

What were BTCY's earnings last quarter?

On Invalid Date, Biotricity (NASDAQ: BTCY) reported Q4 2023 earnings per share (EPS) of -$0.34, up 37.91% year over year. Total Biotricity earnings for the quarter were -$3.05 million. In the same quarter last year, Biotricity's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Biotricity stock.

What was BTCY's earnings growth in the past year?

As of Q2 2024, Biotricity's earnings has grown year over year. Biotricity's earnings in the past year totalled -$15.39 million.

What is BTCY's earnings date?

Biotricity's earnings date is Invalid Date. Add BTCY to your watchlist to be reminded of BTCY's next earnings announcement.

What was BTCY's revenue last quarter?

On Invalid Date, Biotricity (NASDAQ: BTCY) reported Q4 2023 revenue of $2.97 million up 20.89% year over year. In the same quarter last year, Biotricity's revenue was $2.46 million.

What was BTCY's revenue growth in the past year?

As of Q2 2024, Biotricity's revenue has grown 28.55% year over year. This is 17.86 percentage points higher than the US Medical Devices industry revenue growth rate of 10.68%. Biotricity's revenue in the past year totalled $11.63 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.